The CRISPR gene-editing tool can be used to silence an important hepatitis B virus gene, a proof-of-concept in vitro study suggests. "It's the first time we've seen CRISPR editing done in a hepatitis ...
Researchers in gastroenterology and hepatology at HKUMed are pioneering gene-related therapy for chronic hepatitis B infection, potentially enabling patients to discontinue long-term medication and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results